Home    Back

Platelet rich plasma    (DrugBank: -)

2 diseases
IDDisease name (Link within this page)Number of trials
46Malignant rheumatoid arthritis1
90Retinitis pigmentosa2

46. Malignant rheumatoid arthritis    [ 4,183 clinical trials,   2,538 drugs,   (DrugBank: 401 drugs),   183 drug target genes,   219 drug target pathways]
Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 4,183 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2006-005391-40-IT
(EUCTR)		25/09/200605/06/2007Study on the effect of intra-articular infiltrations of aulogous platelet gel as inhibitor of erosion in rheumatoid arthritis patients - NDStudy on the effect of intra-articular infiltrations of aulogous platelet gel as inhibitor of erosion in rheumatoid arthritis patients - ND Patients with Rheumatoid Arthritis
Level: PTClassification code 10039073		Product Name: Platelet Rich Plasma
INN or Proposed INN: Triamcinolone		AZIENDA OSPEDALIERA SENESENULLNot RecruitingFemale: yes
Male: yes		Italy

90. Retinitis pigmentosa    [ 103 clinical trials,   158 drugs,   (DrugBank: 42 drugs),   52 drug target genes,   107 drug target pathways]
Searched query = "Retinitis pigmentosa", "Rod dystrophy", "Rod-Cone Dystrophy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 103 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04252534
(ClinicalTrials.gov)		January 1, 201731/1/2020Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich PlasmaManagement of Retinitis Pigmentosa Via Repetitive Electromagnetic Stimulation and Autologous Platelet Rich PlasmaRetinitis PigmentosaCombination Product: PRP combined Magnovision;Biological: PRPAnkara Universitesi TeknokentNULLCompleted18 Years60 YearsAll60N/ANULL
2NCT04238858
(ClinicalTrials.gov)		September 1, 201618/1/2020Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis PigmentosaEffects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis PigmentosaRetinitis PigmentosaBiological: Platelet rich plasmaAnkara Universitesi TeknokentNULLCompleted18 Years55 YearsAll48N/ATurkey